Literature DB >> 7641829

Prevalence of hepatitis A antibody among disadvantaged gypsy children in northern Spain.

G Cilla1, E Perez-Trallero, J M Marimon, S Erdozain, C Gutierrez.   

Abstract

The prevalence of antibody to hepatitis A virus (HAV) in a group of socially and economically disadvantaged Spanish gypsy children was compared to that of a group of non-gypsy middle-class children. The study included 438 children, 73 gypsies (38 girls and 35 boys, mean age 8.5 years, age range 2-16 years) and 365 non-gypsy controls, randomly selected by age. The presence of anti-HAV was investigated using ELISA. Among the gypsy children, 82% had antibodies to HAV compared with 9.3% of the children in the control group. The unfavourable living conditions of the gypsy population (e.g. homes with poor sanitary conditions, overcrowding) may explain the high prevalence of HAV infection. These findings underline the need for specific action which targets disadvantaged populations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641829      PMCID: PMC2271562          DOI: 10.1017/s0950268800058210

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  14 in total

1.  Hepatitis A.

Authors:  A J Tilzey; J E Banatvala
Journal:  BMJ       Date:  1991-06-29

2.  [Seroprotection against hepatitis A, measles, rubella, and parotiditis in an urban school population].

Authors:  A Gil; A González; R Dal-Ré; L Aguilar; J Rey Calero
Journal:  Med Clin (Barc)       Date:  1991-05-11       Impact factor: 1.725

3.  Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers.

Authors:  B Flehmig; U Heinricy; M Pfisterer
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

4.  Hepatitis A among drug abusers.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1988-05-20       Impact factor: 17.586

5.  Prevalence of hepatitis virus infections in Albanian refugees.

Authors:  T Santantonio; S Lo Caputo; C Germinario; S Squarcione; D Greco; V Laddago; G Pastore
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

Review 6.  Epidemiological patterns of hepatitis A in different parts of the world.

Authors:  I D Gust
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

7.  Epidemiology of hepatitis A in Mediterranean countries.

Authors:  G Papaevangelou
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

8.  Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA.

Authors:  C N Shapiro; P J Coleman; G M McQuillan; M J Alter; H S Margolis
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

9.  Frequency of illness associated with epidemic hepatitis A virus infections in adults.

Authors:  W M Lednar; S M Lemon; J W Kirkpatrick; R R Redfield; M L Fields; P W Kelley
Journal:  Am J Epidemiol       Date:  1985-08       Impact factor: 4.897

10.  Antibody to hepatitis A antigen in institutionalized mentally retarded patients.

Authors:  W Szmuness; R H Purcell; J L Dienstag; C E Stevens
Journal:  JAMA       Date:  1977-04-18       Impact factor: 56.272

View more
  4 in total

Review 1.  The health of the Roma people: a review of the published literature.

Authors:  S Hajioff; M McKee
Journal:  J Epidemiol Community Health       Date:  2000-11       Impact factor: 3.710

2.  Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain.

Authors:  G Cilla; A Sarasua; M Montes; N Arostegui; D Vicente; E Pérez-Yarza; E Pérez-Trallero
Journal:  Epidemiol Infect       Date:  2006-06       Impact factor: 2.451

3.  Seroprevalence of viral hepatitis A in the Czech Republic.

Authors:  J Beran; P Douda; R Rychlý
Journal:  Eur J Epidemiol       Date:  1999-10       Impact factor: 8.082

Review 4.  Hepatotropic viruses: Is Roma population at risk?

Authors:  Anna Mrzljak; Lucija Bajkovec; Tatjana Vilibic-Cavlek
Journal:  World J Gastroenterol       Date:  2021-01-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.